<?xml version="1.0" encoding="UTF-8"?>
<p id="par0095">The rapid spread and the death toll of the new SARS-CoV-2 epidemic warrants the immediate identification / development of effective antiviral agents and vaccines, and the design of accurate diagnostics as well. The intra- and inter- patient variability affects the compatibility of molecular diagnostics but also impairs the effectiveness of the vaccines and the serological assays by altering the antigenicity of the virus.</p>
